更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
奥莱玛制药:罗氏MBC数据推动股价翻倍——我主张谨慎行事(纳斯达克:OLMA)- 寻求阿尔法
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution (NASDAQ:OLMA) Seeking Alpha
罗氏乳腺癌药物试验结果积极,股价应声上涨——《华尔街日报》
Roche Shares Rise After Breast-Cancer Pill Shows Positive Results in Trial The Wall Street Journal
罗氏口服药物证实可抑制乳腺癌复发,提振股价——路透社
Roche oral drug shown to keep breast cancer at bay, boosting shares Reuters
因中国将解除测序仪出口禁令,Illumina股价上涨——Fierce Biotech报道
Illumina shares rise as China set to lift sequencer export ban Fierce Biotech
罗氏股价因新药销售不佳而下跌——路透社
Roche shares fall as new drug sales disappoint Reuters
Astrana Health、Privia Health、Illumina、Waters Corporation及LeMaitre股价暴跌,关键信息解读 - 雅虎财经
Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know Yahoo Finance
NeoGenomics、Progyny、Repligen、Revvity及Waters公司股价飙升,投资者须知要点 - 雅虎财经
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know Yahoo Finance
JPM 2025:龙沙集团分享CHI退出与收购战略展望——聚焦制药技术领域
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy Pharmaceutical Technology
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页